The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects

被引:0
作者
Bo Tan
Yi-Fan Zhang
Xiao-Yan Chen
Xiao-Hua Zhao
Guo-Xin Li
Da-Fang Zhong
机构
[1] Chinese Academy of Sciences,Shanghai Institute of Materia Medica
[2] Liaoning University of Traditional Chinese Medicine,Departmant of Clinical Pharmacology, The Second Affiliated Hospital
来源
European Journal of Clinical Pharmacology | 2010年 / 66卷
关键词
Glipizide; Genetic polymorphism; Pharmacokinetics; Pharmacodynamics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:145 / 151
页数:6
相关论文
共 73 条
  • [51] Kim RB(undefined)undefined undefined undefined undefined-undefined
  • [52] Stein CM(undefined)undefined undefined undefined undefined-undefined
  • [53] Lee CR(undefined)undefined undefined undefined undefined-undefined
  • [54] Goldstein JA(undefined)undefined undefined undefined undefined-undefined
  • [55] Pieper JA(undefined)undefined undefined undefined undefined-undefined
  • [56] Sim SC(undefined)undefined undefined undefined undefined-undefined
  • [57] Risinger C(undefined)undefined undefined undefined undefined-undefined
  • [58] Dahl ML(undefined)undefined undefined undefined undefined-undefined
  • [59] Aklillu E(undefined)undefined undefined undefined undefined-undefined
  • [60] Christensen M(undefined)undefined undefined undefined undefined-undefined